ORAGENICS, INC. Selling, General and Administrative Expense
ORAGENICS, INC. (OGEN) reported Selling, General and Administrative Expense of $920.72 thousand for the 3-month period ending 2016-06-30, per its 10-Q filed 2016-08-15.
Discontinued › Expense Statement › Operating Expenses
us-gaap:SellingGeneralAndAdministrativeExpense · last filed 2016-08-15
- ORAGENICS, INC. selling, general and administrative expense for the quarter ending 2016-06-30 was $920.72K, a 25.73% increase year-over-year.
- ORAGENICS, INC. selling, general and administrative expense for the quarter ending 2016-03-31 was $994.43K, a 21.95% increase year-over-year.
- ORAGENICS, INC. selling, general and administrative expense for the quarter ending 2015-12-31 was $1.00M, a 23.18% increase year-over-year.
- ORAGENICS, INC. selling, general and administrative expense for the quarter ending 2015-09-30 was $853.92K, a 51.11% increase year-over-year.
- ORAGENICS, INC. selling, general and administrative expense for fiscal 2015 was $3.54M, a 6.67% increase from fiscal 2014.
- ORAGENICS, INC. selling, general and administrative expense for fiscal 2014 was $3.32M, a 55.95% decline from fiscal 2013.
- ORAGENICS, INC. selling, general and administrative expense for fiscal 2013 was $7.54M, a 50.06% increase from fiscal 2012.
- ORAGENICS, INC. selling, general and administrative expense for fiscal 2012 was $5.02M, a 10.72% decline from fiscal 2011.
| Period end | Selling, General and Administrative Expense 3 month | Selling, General and Administrative Expense 6 month | Selling, General and Administrative Expense 6 month as first filed | Selling, General and Administrative Expense 9 month | Selling, General and Administrative Expense 12 month |
|---|---|---|---|---|---|
| 2016-06-30 | $920.72K 10-Q · filed 2016-08-15 | $1.75M 10-Q · filed 2016-08-15 | $2.92M derived: sum of 3 quarters · filed 2016-08-15 | $3.77M derived: sum of 4 quarters · filed 2016-08-15 | |
| 2016-03-31 | $994.43K 10-Q · filed 2016-05-16 | $1.99M derived: sum of 2 quarters · filed 2016-05-16 | $2.85M derived: sum of 3 quarters · filed 2016-05-16 | $3.72M derived: sum of 4 quarters · filed 2016-05-16 | |
| 2015-12-31 | $1.00M derived: 10-K 12 month − 10-Q 9 month · filed 2016-03-30 | $1.85M derived: sum of 2 quarters · filed 2016-03-30 | $2.73M derived: sum of 3 quarters · filed 2016-03-30 | $3.54M 10-K · filed 2016-03-30 | |
| 2015-09-30 | $853.92K 10-Q · filed 2015-11-06 | $1.73M derived: sum of 2 quarters · filed 2015-11-06 | $2.54M 10-Q · filed 2015-11-06 | $3.35M derived: sum of 4 quarters · filed 2016-05-16 | |
| 2015-06-30 | $732.30K 10-Q · filed 2016-08-15 | $1.43M 10-Q · filed 2016-08-15 | $1.69M 10-Q · filed 2015-08-07 | $2.50M derived: sum of 3 quarters · filed 2016-05-16 | $3.07M derived: sum of 4 quarters · filed 2016-05-16 |
| 2015-03-31 | $815.47K 10-Q · filed 2016-05-16 | $1.63M derived: sum of 2 quarters · filed 2016-05-16 | $2.19M derived: sum of 3 quarters · filed 2016-05-16 | $3.37M derived: sum of 4 quarters · filed 2016-05-16 | |
| 2014-12-31 | $811.93K derived: 10-K 12 month − 10-Q 9 month · filed 2016-03-30 | $1.38M derived: sum of 2 quarters · filed 2016-03-30 | $2.55M derived: sum of 3 quarters · filed 2016-03-30 | $3.32M 10-K · filed 2016-03-30 | |
| 2014-09-30 | $565.11K 10-Q · filed 2015-11-06 | $1.74M derived: sum of 2 quarters · filed 2015-11-06 | $2.51M 10-Q · filed 2015-11-06 | $4.87M derived: sum of 4 quarters · filed 2015-11-06 | |
| 2014-06-30 | $1.18M 10-Q · filed 2015-08-07 | $1.94M 10-Q · filed 2015-08-07 | $4.30M derived: sum of 3 quarters · filed 2015-08-07 | $6.86M derived: sum of 4 quarters · filed 2015-08-07 | |
| 2014-03-31 | $767.39K 10-Q · filed 2015-05-08 | $3.13M derived: sum of 2 quarters · filed 2015-05-08 | $5.69M derived: sum of 3 quarters · filed 2015-05-08 | $7.20M derived: sum of 4 quarters · filed 2015-05-08 | |
| 2013-12-31 | $2.36M derived: 10-K 12 month − 10-Q 9 month · filed 2015-02-27 | $4.92M derived: sum of 2 quarters · filed 2015-02-27 | $6.44M derived: sum of 3 quarters · filed 2015-02-27 | $7.54M 10-K · filed 2015-02-27 | |
| 2013-09-30 | $2.56M 10-Q · filed 2014-11-03 | $4.08M derived: sum of 2 quarters · filed 2014-11-03 | $5.18M 10-Q · filed 2014-11-03 | $6.47M derived: sum of 4 quarters · filed 2014-11-03 | |
| 2013-06-30 | $1.52M 10-Q · filed 2014-08-07 | $2.62M 10-Q · filed 2014-08-07 | $3.91M derived: sum of 3 quarters · filed 2014-08-07 | $5.50M derived: sum of 4 quarters · filed 2014-08-07 | |
| 2013-03-31 | $1.10M 10-Q · filed 2014-05-09 | $2.39M derived: sum of 2 quarters · filed 2014-05-09 | $3.98M derived: sum of 3 quarters · filed 2014-05-09 | $4.82M derived: sum of 4 quarters · filed 2014-05-09 | |
| 2012-12-31 | $1.28M derived: 10-K 12 month − 10-Q 9 month · filed 2014-02-28 | $2.88M derived: sum of 2 quarters · filed 2014-02-28 | $3.72M derived: sum of 3 quarters · filed 2014-02-28 | $5.02M 10-K · filed 2014-02-28 | |
| 2012-09-30 | $1.60M 10-Q · filed 2013-10-25 | $2.43M derived: sum of 2 quarters · filed 2013-10-25 | $3.74M 10-Q · filed 2013-10-25 | $4.95M derived: sum of 4 quarters · filed 2013-10-25 | |
| 2012-06-30 | $835.47K 10-Q · filed 2013-08-12 | $2.14M 10-Q · filed 2013-08-12 | $3.36M derived: sum of 3 quarters · filed 2013-08-12 | $4.72M derived: sum of 4 quarters · filed 2013-08-12 | |
| 2012-03-31 | $1.31M 10-Q · filed 2013-05-15 | $2.52M derived: sum of 2 quarters · filed 2013-05-15 | $3.89M derived: sum of 3 quarters · filed 2013-05-15 | $5.58M derived: sum of 4 quarters · filed 2013-05-15 | |
| 2011-12-31 | $1.21M derived: 10-K 12 month − 10-Q 9 month · filed 2013-03-26 | $2.58M derived: sum of 2 quarters · filed 2013-03-26 | $4.27M derived: sum of 3 quarters · filed 2013-03-26 | $5.63M 10-K · filed 2013-03-26 | |
| 2011-09-30 | $1.36M 10-Q · filed 2012-11-14 | $3.06M derived: sum of 2 quarters · filed 2012-11-14 | $4.41M 10-Q · filed 2012-11-14 | $5.91M derived: sum of 4 quarters · filed 2012-11-14 | |
| 2011-06-30 | $1.69M 10-Q · filed 2012-08-10 | $3.05M 10-Q · filed 2012-08-10 | $4.54M derived: sum of 3 quarters · filed 2012-08-10 | $6.17M derived: sum of 4 quarters · filed 2012-08-10 | |
| 2011-03-31 | $1.36M 10-Q · filed 2012-05-15 | $2.85M derived: sum of 2 quarters · filed 2012-05-15 | $4.47M derived: sum of 3 quarters · filed 2012-05-15 | $6.20M derived: sum of 4 quarters · filed 2012-05-15 | |
| 2010-12-31 | $1.49M derived: 10-K 12 month − 10-Q 9 month · filed 2012-04-16 | $3.12M derived: sum of 2 quarters · filed 2012-04-16 | $4.84M derived: sum of 3 quarters · filed 2012-04-16 | $6.29M 10-K · filed 2012-04-16 | |
| 2010-09-30 | $1.62M 10-Q · filed 2011-11-14 | $3.35M derived: sum of 2 quarters · filed 2011-11-14 | $4.79M 10-Q · filed 2011-11-14 | ||
| 2010-06-30 | $1.72M 10-Q · filed 2011-08-05 | $3.17M 10-Q · filed 2011-08-05 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| JUPITER NEUROSCIENCES, INC. (JUNS) | United States | $0.002B | -0.02 |
| BioXcel Therapeutics, Inc. (BTAI) | United States | $0.002B | |
| Nexentis Technologies Inc. (NXTS) | $0.002B | ||
| Decoy Therapeutics Inc. (DCOY) | United States | $0.002B | -0.27 |
| ZyVersa Therapeutics, Inc. (ZVSA) | United States | $0.002B | |
| Matinas BioPharma Holdings, Inc. (MTNB) | United States | $0.003B | |
| Petros Pharmaceuticals, Inc. (PTPI) | United States | $0.003B | |
| GeoVax Labs, Inc. (GOVX) | United States | $0.003B | -0.45 |
| Silo Pharma, Inc. (SILO) | United States | $0.003B | -1.57 |
| Genprex, Inc. (GNPX) | United States | $0.003B | -0.02 |